LifeMD Q4 Revenue Beats by 5.9% as Loss Widens to $0.04
LifeMD reported a Q4 loss of $0.04 per share, missing consensus by $0.03 and marking a -300% earnings surprise, while revenue fell 27% year-over-year to $46.87 million, topping estimates by 5.9%. Shares have declined about 12% year-to-date as the Medical Services industry ranks in the bottom 45%.
1. Q4 Financial Results
LifeMD posted a fourth-quarter adjusted loss of $0.04 per share, compared with an expected loss of $0.01, representing a -300% earnings surprise. Revenue declined 27% year-over-year to $46.87 million but outpaced consensus by 5.92%, marking the second revenue beat in four quarters.
2. Year-to-Date Share Performance
Shares of LifeMD have fallen about 12% since January 1, underperforming the S&P 500's 1.5% decline, as investors weighed the earnings miss against the revenue beat. The company has surpassed EPS estimates only once in the past four quarters, raising concerns about consistency.
3. Outlook and Industry Context
Analyst consensus for the next quarter calls for a loss of $0.22 per share on $49.4 million in revenue, while full-year forecasts project a $0.61 per-share loss on $215.1 million in sales. The Medical Services industry sits in the bottom 45% of rankings, suggesting headwinds for sector peers ahead.